SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001578563-24-000186
Filing Date
2024-04-09
Accepted
2024-04-09 16:58:14
Documents
1
Effectiveness Date
2024-04-09
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 12992
  Complete submission text file 0001578563-24-000186.txt   14260
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Avalo Therapeutics, Inc. (Filer) CIK: 0001534120 (see all company filings)

IRS No.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-510110 | Film No.: 24833374
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)